N-(1H-benzimidazol-2-ylmethyl)-N-benzyl-2-(2-pyridin-2-ylhydrazinyl)pyrimidine-4-carboxamide;N-benzyl-N-[[2-(2-benzylhydrazinyl)-4-(trifluoromethyl)pyrimidin-5-yl]methyl]benzenesulfonamide;N-[[2-(2-benzylhydrazinyl)pyrimidin-4-yl]methyl]-N-(5,6,7,8-tetrahydroquinolin-8-yl)benzamide;N-[[2-(2-benzylhydrazinyl)-4-(trifluoromethyl)pyrimidin-5-yl]methyl]-1-phenylmethanamine;N,N-dibenzyl-2-(2-benzylhydrazinyl)pyrimidine-4-carboxamide

C125H119F6N29O5S — CID 158918053

IUPACN-(1H-benzimidazol-2-ylmethyl)-N-benzyl-2-(2-pyridin-2-ylhydrazinyl)pyrimidine-4-carboxamide;N-benzyl-N-[[2-(2-benzylhydrazinyl)-4-(trifluoromethyl)pyrimidin-5-yl]methyl]benzenesulfonamide;N-[[2-(2-benzylhydrazinyl)pyrimidin-4-yl]methyl]-N-(5,6,7,8-tetrahydroquinolin-8-yl)benzamide;N-[[2-(2-benzylhydrazinyl)-4-(trifluoromethyl)pyrimidin-5-yl]methyl]-1-phenylmethanamine;N,N-dibenzyl-2-(2-benzylhydrazinyl)pyrimidine-4-carboxamide
SMILESFC(F)(F)c1nc(NNCc2ccccc2)ncc1CNCc1ccccc1.O=C(c1ccccc1)N(Cc1ccnc(NNCc2ccccc2)n1)C1CCCc2cccnc21.O=C(c1ccnc(NNCc2ccccc2)n1)N(Cc1ccccc1)Cc1ccccc1.O=C(c1ccnc(NNc2ccccn2)n1)N(Cc1ccccc1)Cc1nc2ccccc2[nH]1.O=S(=O)(c1ccccc1)N(Cc1ccccc1)Cc1cnc(NNCc2ccccc2)nc1C(F)(F)F
InChIInChI=1S/C28H28N6O.C26H24F3N5O2S.C26H25N5O.C25H22N8O.C20H20F3N5/c35-27(23-11-5-2-6-12-23)34(25-15-7-13-22-14-8-17-29-26(22)25)20-24-16-18-30-28(32-24)33-31-19-21-9-3-1-4-10-21;27-26(28,29)24-22(17-30-25(32-24)33-31-16-20-10-4-1-5-11-20)19-34(18-21-12-6-2-7-13-21)37(35,36)23-14-8-3-9-15-23;32-25(24-16-17-27-26(29-24)30-28-18-21-10-4-1-5-11-21)31(19-22-12-6-2-7-13-22)20-23-14-8-3-9-15-23;34-24(21-13-15-27-25(30-21)32-31-22-12-6-7-14-26-22)33(16-18-8-2-1-3-9-18)17-23-28-19-10-4-5-11-20(19)29-23;21-20(22,23)18-17(13-24-11-15-7-3-1-4-8-15)14-25-19(27-18)28-26-12-16-9-5-2-6-10-16/h1-6,8-12,14,16-18,25,31H,7,13,15,19-20H2,(H,30,32,33);1-15,17,31H,16,18-19H2,(H,30,32,33);1-17,28H,18-20H2,(H,27,29,30);1-15H,16-17H2,(H,26,31)(H,28,29)(H,27,30,32);1-10,14,24,26H,11-13H2,(H,25,27,28)
InChIKeyJHMGENJEJVHVDE-UHFFFAOYSA-N
MW2253.58 g/mol
LogP22.08
Rot. Bonds43

About N-(1H-benzimidazol-2-ylmethyl)-N-benzyl-2-(2-pyridin-2-ylhydrazinyl)pyrimidine-4-carboxamide;N-benzyl-N-[[2-(2-benzylhydrazinyl)-4-(trifluoromethyl)pyrimidin-5-yl]methyl]benzenesulfonamide;N-[[2-(2-benzylhydrazinyl)pyrimidin-4-yl]methyl]-N-(5,6,7,8-tetrahydroquinolin-8-yl)benzamide;N-[[2-(2-benzylhydrazinyl)-4-(trifluoromethyl)pyrimidin-5-yl]methyl]-1-phenylmethanamine;N,N-dibenzyl-2-(2-benzylhydrazinyl)pyrimidine-4-carboxamide

N-(1H-benzimidazol-2-ylmethyl)-N-benzyl-2-(2-pyridin-2-ylhydrazinyl)pyrimidine-4-carboxamide;N-benzyl-N-[[2-(2-benzylhydrazinyl)-4-(trifluoromethyl)pyrimidin-5-yl]methyl]benzenesulfonamide;N-[[2-(2-benzylhydrazinyl)pyrimidin-4-yl]methyl]-N-(5,6,7,8-tetrahydroquinolin-8-yl)benzamide;N-[[2-(2-benzylhydrazinyl)-4-(trifluoromethyl)pyrimidin-5-yl]methyl]-1-phenylmethanamine;N,N-dibenzyl-2-(2-benzylhydrazinyl)pyrimidine-4-carboxamide (PubChem CID 158918053) has the molecular formula C125H119F6N29O5S and a molecular weight of 2253.58 g/mol. Its IUPAC name is N-(1H-benzimidazol-2-ylmethyl)-N-benzyl-2-(2-pyridin-2-ylhydrazinyl)pyrimidine-4-carboxamide;N-benzyl-N-[[2-(2-benzylhydrazinyl)-4-(trifluoromethyl)pyrimidin-5-yl]methyl]benzenesulfonamide;N-[[2-(2-benzylhydrazinyl)pyrimidin-4-yl]methyl]-N-(5,6,7,8-tetrahydroquinolin-8-yl)benzamide;N-[[2-(2-benzylhydrazinyl)-4-(trifluoromethyl)pyrimidin-5-yl]methyl]-1-phenylmethanamine;N,N-dibenzyl-2-(2-benzylhydrazinyl)pyrimidine-4-carboxamide.

Molecular Properties

Compound NameN-(1H-benzimidazol-2-ylmethyl)-N-benzyl-2-(2-pyridin-2-ylhydrazinyl)pyrimidine-4-carboxamide;N-benzyl-N-[[2-(2-benzylhydrazinyl)-4-(trifluoromethyl)pyrimidin-5-yl]methyl]benzenesulfonamide;N-[[2-(2-benzylhydrazinyl)pyrimidin-4-yl]methyl]-N-(5,6,7,8-tetrahydroquinolin-8-yl)benzamide;N-[[2-(2-benzylhydrazinyl)-4-(trifluoromethyl)pyrimidin-5-yl]methyl]-1-phenylmethanamine;N,N-dibenzyl-2-(2-benzylhydrazinyl)pyrimidine-4-carboxamide
PubChem CID158918053
Molecular FormulaC125H119F6N29O5S
Molecular Weight2253.58 g/mol
Exact Mass2251.96
IUPAC NameN-(1H-benzimidazol-2-ylmethyl)-N-benzyl-2-(2-pyridin-2-ylhydrazinyl)pyrimidine-4-carboxamide;N-benzyl-N-[[2-(2-benzylhydrazinyl)-4-(trifluoromethyl)pyrimidin-5-yl]methyl]benzenesulfonamide;N-[[2-(2-benzylhydrazinyl)pyrimidin-4-yl]methyl]-N-(5,6,7,8-tetrahydroquinolin-8-yl)benzamide;N-[[2-(2-benzylhydrazinyl)-4-(trifluoromethyl)pyrimidin-5-yl]methyl]-1-phenylmethanamine;N,N-dibenzyl-2-(2-benzylhydrazinyl)pyrimidine-4-carboxamide
SMILESFC(F)(F)c1nc(NNCc2ccccc2)ncc1CNCc1ccccc1.O=C(c1ccccc1)N(Cc1ccnc(NNCc2ccccc2)n1)C1CCCc2cccnc21.O=C(c1ccnc(NNCc2ccccc2)n1)N(Cc1ccccc1)Cc1ccccc1.O=C(c1ccnc(NNc2ccccn2)n1)N(Cc1ccccc1)Cc1nc2ccccc2[nH]1.O=S(=O)(c1ccccc1)N(Cc1ccccc1)Cc1cnc(NNCc2ccccc2)nc1C(F)(F)F
InChIInChI=1S/C28H28N6O.C26H24F3N5O2S.C26H25N5O.C25H22N8O.C20H20F3N5/c35-27(23-11-5-2-6-12-23)34(25-15-7-13-22-14-8-17-29-26(22)25)20-24-16-18-30-28(32-24)33-31-19-21-9-3-1-4-10-21;27-26(28,29)24-22(17-30-25(32-24)33-31-16-20-10-4-1-5-11-20)19-34(18-21-12-6-2-7-13-21)37(35,36)23-14-8-3-9-15-23;32-25(24-16-17-27-26(29-24)30-28-18-21-10-4-1-5-11-21)31(19-22-12-6-2-7-13-22)20-23-14-8-3-9-15-23;34-24(21-13-15-27-25(30-21)32-31-22-12-6-7-14-26-22)33(16-18-8-2-1-3-9-18)17-23-28-19-10-4-5-11-20(19)29-23;21-20(22,23)18-17(13-24-11-15-7-3-1-4-8-15)14-25-19(27-18)28-26-12-16-9-5-2-6-10-16/h1-6,8-12,14,16-18,25,31H,7,13,15,19-20H2,(H,30,32,33);1-15,17,31H,16,18-19H2,(H,30,32,33);1-17,28H,18-20H2,(H,27,29,30);1-15H,16-17H2,(H,26,31)(H,28,29)(H,27,30,32);1-10,14,24,26H,11-13H2,(H,25,27,28)
InChIKeyJHMGENJEJVHVDE-UHFFFAOYSA-N
XLogP22.08
TPSA414.00 Ų
H-Bond Donors12
H-Bond Acceptors29
Rotatable Bonds43
Heavy Atoms166
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002253.58
LogP ≤ 522.08
H-Bond Donors ≤ 512
H-Bond Acceptors ≤ 1029

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze N-(1H-benzimidazol-2-ylmethyl)-N-benzyl-2-(2-pyridin-2-ylhydrazinyl)pyrimidine-4-carboxamide;N-benzyl-N-[[2-(2-benzylhydrazinyl)-4-(trifluoromethyl)pyrimidin-5-yl]methyl]benzenesulfonamide;N-[[2-(2-benzylhydrazinyl)pyrimidin-4-yl]methyl]-N-(5,6,7,8-tetrahydroquinolin-8-yl)benzamide;N-[[2-(2-benzylhydrazinyl)-4-(trifluoromethyl)pyrimidin-5-yl]methyl]-1-phenylmethanamine;N,N-dibenzyl-2-(2-benzylhydrazinyl)pyrimidine-4-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-(1H-benzimidazol-2-ylmethyl)-N-benzyl-2-(2-pyridin-2-ylhydrazinyl)pyrimidine-4-carboxamide;N-benzyl-N-[[2-(2-benzylhydrazinyl)-4-(trifluoromethyl)pyrimidin-5-yl]methyl]benzenesulfonamide;N-[[2-(2-benzylhydrazinyl)pyrimidin-4-yl]methyl]-N-(5,6,7,8-tetrahydroquinolin-8-yl)benzamide;N-[[2-(2-benzylhydrazinyl)-4-(trifluoromethyl)pyrimidin-5-yl]methyl]-1-phenylmethanamine;N,N-dibenzyl-2-(2-benzylhydrazinyl)pyrimidine-4-carboxamide?
The IUPAC name of N-(1H-benzimidazol-2-ylmethyl)-N-benzyl-2-(2-pyridin-2-ylhydrazinyl)pyrimidine-4-carboxamide;N-benzyl-N-[[2-(2-benzylhydrazinyl)-4-(trifluoromethyl)pyrimidin-5-yl]methyl]benzenesulfonamide;N-[[2-(2-benzylhydrazinyl)pyrimidin-4-yl]methyl]-N-(5,6,7,8-tetrahydroquinolin-8-yl)benzamide;N-[[2-(2-benzylhydrazinyl)-4-(trifluoromethyl)pyrimidin-5-yl]methyl]-1-phenylmethanamine;N,N-dibenzyl-2-(2-benzylhydrazinyl)pyrimidine-4-carboxamide (CID 158918053) is N-(1H-benzimidazol-2-ylmethyl)-N-benzyl-2-(2-pyridin-2-ylhydrazinyl)pyrimidine-4-carboxamide;N-benzyl-N-[[2-(2-benzylhydrazinyl)-4-(trifluoromethyl)pyrimidin-5-yl]methyl]benzenesulfonamide;N-[[2-(2-benzylhydrazinyl)pyrimidin-4-yl]methyl]-N-(5,6,7,8-tetrahydroquinolin-8-yl)benzamide;N-[[2-(2-benzylhydrazinyl)-4-(trifluoromethyl)pyrimidin-5-yl]methyl]-1-phenylmethanamine;N,N-dibenzyl-2-(2-benzylhydrazinyl)pyrimidine-4-carboxamide.
What is the SMILES notation for N-(1H-benzimidazol-2-ylmethyl)-N-benzyl-2-(2-pyridin-2-ylhydrazinyl)pyrimidine-4-carboxamide;N-benzyl-N-[[2-(2-benzylhydrazinyl)-4-(trifluoromethyl)pyrimidin-5-yl]methyl]benzenesulfonamide;N-[[2-(2-benzylhydrazinyl)pyrimidin-4-yl]methyl]-N-(5,6,7,8-tetrahydroquinolin-8-yl)benzamide;N-[[2-(2-benzylhydrazinyl)-4-(trifluoromethyl)pyrimidin-5-yl]methyl]-1-phenylmethanamine;N,N-dibenzyl-2-(2-benzylhydrazinyl)pyrimidine-4-carboxamide?
The canonical SMILES for N-(1H-benzimidazol-2-ylmethyl)-N-benzyl-2-(2-pyridin-2-ylhydrazinyl)pyrimidine-4-carboxamide;N-benzyl-N-[[2-(2-benzylhydrazinyl)-4-(trifluoromethyl)pyrimidin-5-yl]methyl]benzenesulfonamide;N-[[2-(2-benzylhydrazinyl)pyrimidin-4-yl]methyl]-N-(5,6,7,8-tetrahydroquinolin-8-yl)benzamide;N-[[2-(2-benzylhydrazinyl)-4-(trifluoromethyl)pyrimidin-5-yl]methyl]-1-phenylmethanamine;N,N-dibenzyl-2-(2-benzylhydrazinyl)pyrimidine-4-carboxamide is FC(F)(F)c1nc(NNCc2ccccc2)ncc1CNCc1ccccc1.O=C(c1ccccc1)N(Cc1ccnc(NNCc2ccccc2)n1)C1CCCc2cccnc21.O=C(c1ccnc(NNCc2ccccc2)n1)N(Cc1ccccc1)Cc1ccccc1.O=C(c1ccnc(NNc2ccccn2)n1)N(Cc1ccccc1)Cc1nc2ccccc2[nH]1.O=S(=O)(c1ccccc1)N(Cc1ccccc1)Cc1cnc(NNCc2ccccc2)nc1C(F)(F)F.
What is the InChIKey of N-(1H-benzimidazol-2-ylmethyl)-N-benzyl-2-(2-pyridin-2-ylhydrazinyl)pyrimidine-4-carboxamide;N-benzyl-N-[[2-(2-benzylhydrazinyl)-4-(trifluoromethyl)pyrimidin-5-yl]methyl]benzenesulfonamide;N-[[2-(2-benzylhydrazinyl)pyrimidin-4-yl]methyl]-N-(5,6,7,8-tetrahydroquinolin-8-yl)benzamide;N-[[2-(2-benzylhydrazinyl)-4-(trifluoromethyl)pyrimidin-5-yl]methyl]-1-phenylmethanamine;N,N-dibenzyl-2-(2-benzylhydrazinyl)pyrimidine-4-carboxamide?
The InChIKey is JHMGENJEJVHVDE-UHFFFAOYSA-N. The full InChI is InChI=1S/C28H28N6O.C26H24F3N5O2S.C26H25N5O.C25H22N8O.C20H20F3N5/c35-27(23-11-5-2-6-12-23)34(25-15-7-13-22-14-8-17-29-26(22)25)20-24-16-18-30-28(32-24)33-31-19-21-9-3-1-4-10-21;27-26(28,29)24-22(17-30-25(32-24)33-31-16-20-10-4-1-5-11-20)19-34(18-21-12-6-2-7-13-21)37(35,36)23-14-8-3-9-15-23;32-25(24-16-17-27-26(29-24)30-28-18-21-10-4-1-5-11-21)31(19-22-12-6-2-7-13-22)20-23-14-8-3-9-15-23;34-24(21-13-15-27-25(30-21)32-31-22-12-6-7-14-26-22)33(16-18-8-2-1-3-9-18)17-23-28-19-10-4-5-11-20(19)29-23;21-20(22,23)18-17(13-24-11-15-7-3-1-4-8-15)14-25-19(27-18)28-26-12-16-9-5-2-6-10-16/h1-6,8-12,14,16-18,25,31H,7,13,15,19-20H2,(H,30,32,33);1-15,17,31H,16,18-19H2,(H,30,32,33);1-17,28H,18-20H2,(H,27,29,30);1-15H,16-17H2,(H,26,31)(H,28,29)(H,27,30,32);1-10,14,24,26H,11-13H2,(H,25,27,28).
What are the key properties of N-(1H-benzimidazol-2-ylmethyl)-N-benzyl-2-(2-pyridin-2-ylhydrazinyl)pyrimidine-4-carboxamide;N-benzyl-N-[[2-(2-benzylhydrazinyl)-4-(trifluoromethyl)pyrimidin-5-yl]methyl]benzenesulfonamide;N-[[2-(2-benzylhydrazinyl)pyrimidin-4-yl]methyl]-N-(5,6,7,8-tetrahydroquinolin-8-yl)benzamide;N-[[2-(2-benzylhydrazinyl)-4-(trifluoromethyl)pyrimidin-5-yl]methyl]-1-phenylmethanamine;N,N-dibenzyl-2-(2-benzylhydrazinyl)pyrimidine-4-carboxamide?
N-(1H-benzimidazol-2-ylmethyl)-N-benzyl-2-(2-pyridin-2-ylhydrazinyl)pyrimidine-4-carboxamide;N-benzyl-N-[[2-(2-benzylhydrazinyl)-4-(trifluoromethyl)pyrimidin-5-yl]methyl]benzenesulfonamide;N-[[2-(2-benzylhydrazinyl)pyrimidin-4-yl]methyl]-N-(5,6,7,8-tetrahydroquinolin-8-yl)benzamide;N-[[2-(2-benzylhydrazinyl)-4-(trifluoromethyl)pyrimidin-5-yl]methyl]-1-phenylmethanamine;N,N-dibenzyl-2-(2-benzylhydrazinyl)pyrimidine-4-carboxamide has a molecular weight of 2253.58 g/mol, XLogP of 22.08, 43 rotatable bonds, 12 hydrogen bond donors, and 29 hydrogen bond acceptors.
Where does this data come from?
All data for N-(1H-benzimidazol-2-ylmethyl)-N-benzyl-2-(2-pyridin-2-ylhydrazinyl)pyrimidine-4-carboxamide;N-benzyl-N-[[2-(2-benzylhydrazinyl)-4-(trifluoromethyl)pyrimidin-5-yl]methyl]benzenesulfonamide;N-[[2-(2-benzylhydrazinyl)pyrimidin-4-yl]methyl]-N-(5,6,7,8-tetrahydroquinolin-8-yl)benzamide;N-[[2-(2-benzylhydrazinyl)-4-(trifluoromethyl)pyrimidin-5-yl]methyl]-1-phenylmethanamine;N,N-dibenzyl-2-(2-benzylhydrazinyl)pyrimidine-4-carboxamide is sourced from PubChem (CID 158918053), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).